Article
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
2022-11-01
Abstract excerpt
<title>Abstract</title> <p><bold>background/purpose: </bold>The prognosis of hepatocellular carcinoma (HCC) patients with<bold> </bold>portal vein tumor thrombus (PVTT) is generally poor and hepatectomy is optional for these patients. This study aims to explore the survival benefits of neoadjuvant hepatic arterial infusion chemotherapy (HAIC) for resectable HCC with<bold> </bold>PVTT. <bold>Methods: </bold>This r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e1068578-d030-5af0-86d8-90830490d1f9
- DOI
- 10.21203/rs.3.rs-2170633/v1
